Migraine headache drug recalled after company finds possible microbial contamination
Pfizer recalled two lots of migraine drug Relpax after finding those lots “may not meet Pfizer’s in-house microbiological specification for the potential presence” of two kinds of bacteria. That’s according … Click to Continue »
View original article
Contributor:
